ATLASCelldex Therapeutics (CLDX) earnings date: Nov 9, 2026
Celldex Therapeutics (CLDX) reports earnings for the quarter ended Sep 30, 2026 on Mon, Nov 9, 2026, after the close. Analysts expect EPS of -$1.02.
Source: company filings and exchange data · Updated Nov 2, 2026
ATLAS view on CLDX
| Last price | $30.10 (+0.7%) |
|---|---|
| Normal 1-day range (±1σ) | ±3.0% |
| Earnings beat history | Beat the EPS estimate in 1 of the last 4 reports |
These figures come from the same calibrated model and valuation as the Celldex Therapeutics stock page. They describe an ordinary period, not the earnings reaction itself, which is usually wider and can go either way.
Celldex Therapeutics reports on Nov 9, 2026. One email the day before, with ATLAS’s read on Celldex Therapeutics. You can switch it off at any time.
Alert me before CLDX reportsFree to start. Creating an account takes under a minute.
CLDX earnings at a glance
| Next report (confirmed) | Mon, Nov 9, 2026 |
|---|---|
| Time | After the close |
| Period | Quarter ended Sep 30, 2026 |
| EPS estimate | -$1.02 |
| Last report | Aug 6, 2026 · Beat |
| Beat rate (last 4 reports) | 1 of 4 (25%) |
| Average EPS surprise | -7.1% |
| Average move around a report | ±8.1% (last 4) |
| Sector | Healthcare · Biotechnology |
Celldex Therapeutics earnings history: last 4 reports
Celldex Therapeutics last reported on Aug 6, 2026: EPS of -$0.94 against an estimate of -$1.06 (+11.3% surprise), a beat.
| Report date | EPS est. | EPS actual | Surprise | Result | Move* |
|---|---|---|---|---|---|
| Aug 6, 2026 | -$1.06 | -$0.94 | +11.3% | Beat | +1.6% |
| May 7, 2026 | -$1.13 | -$1.18 | -4.4% | Miss | -1.2% |
| Feb 25, 2026 | -$1.00 | -$1.22 | -22.0% | Miss | +23.4% |
| Nov 10, 2025 | -$0.89 | -$1.01 | -13.5% | Miss | +6.4% |
*Move: change in the closing price from the last close before the report day to the close the day after it, so it captures the reaction whether the company reported before the open or after the close.
Get the full ATLAS analysis for CLDX
See the fair value, the probability range and the earnings history of Celldex Therapeutics on its ATLAS page.
Celldex Therapeutics (CLDX) stock analysisPlans from €3.99 a month.
Celldex Therapeutics earnings: frequently asked questions
When does Celldex Therapeutics (CLDX) report earnings?
Celldex Therapeutics is scheduled to report on Monday, November 9, 2026, after the close. ATLAS only shows a confirmed date when the company or the exchange data provides one; check the investor relations page for the call details.
What is the EPS estimate for CLDX?
The consensus EPS estimate for the quarter ended Sep 30, 2026 is -$1.02 per share (USD). Estimates can change before the report.
How often does CLDX beat earnings estimates?
Of its last 4 reports with a recorded result, Celldex Therapeutics beat the EPS estimate 1 times; the average surprise was -7.1%. Past results do not predict the next one.
How much does CLDX move around earnings?
Over its last 4 reports the stock moved an average of 8.1% (absolute, from the close before the report day to the close after it), and finished higher 3 of 4 times.
Did Celldex Therapeutics beat earnings estimates last quarter?
Celldex Therapeutics last reported on Aug 6, 2026: EPS of -$0.94 against an estimate of -$1.06 (+11.3% surprise), a beat.
How much does CLDX usually move in a day?
On a normal trading day the ATLAS model puts CLDX’s one-day range at about ±3.0%, with a 50% chance of closing higher. This is not an options-implied earnings move; earnings days are usually wider.
Also reporting on Mon, Nov 9, 2026
Educational information, not investment advice. Disclaimer